Anti-Aging Biotechnologies Will Make Social Security and Medicare Obsolete
The cost of healthcare will plummet because healthspans will be significantly extended.
by Patrick Cox
July 31, 2018
Because transfer payments to the aged now make up the biggest part of the federal budget, I continually hear from people who fear anti-aging therapeutics will make things worse.
Extending lives by another few years, they say, will only increase the amount of time that people are receiving transfer payments.
This isn't true. In fact, the opposite will happen.
Social Security and Medicare as we now know them will disappear because they won't be needed.
Right now, biotechnologies that will dramatically extend human healthspans are moving toward the market. Some are already known to those who monitor biogerontology, but others have carefully avoided publicity. When these breakthrough therapies finally arrive, the economy will undergo the most dramatic transformation since the Industrial Revolution.
To understand the future economic impact of longer lifespans, we need at least some grasp of the effects longer lifespans have already had.